Cargando…
Secondary stroke prevention: challenges and solutions
Stroke is the leading cause of disability in the USA and a major cause of mortality worldwide. One out of four strokes is recurrent. Secondary stroke prevention starts with deciphering the most likely stroke mechanism. In general, one of the main goals in stroke reduction is to control vascular risk...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536764/ https://www.ncbi.nlm.nih.gov/pubmed/26300647 http://dx.doi.org/10.2147/VHRM.S63791 |
_version_ | 1782385794222129152 |
---|---|
author | Esenwa, Charles Gutierrez, Jose |
author_facet | Esenwa, Charles Gutierrez, Jose |
author_sort | Esenwa, Charles |
collection | PubMed |
description | Stroke is the leading cause of disability in the USA and a major cause of mortality worldwide. One out of four strokes is recurrent. Secondary stroke prevention starts with deciphering the most likely stroke mechanism. In general, one of the main goals in stroke reduction is to control vascular risk factors such as hypertension, diabetes, dyslipidemia, and smoking cessation. Changes in lifestyle like a healthy diet and aerobic exercise are also recommended strategies. In the case of cardioembolism due to atrial fibrillation, mechanical valves, or cardiac thrombus, anticoagulation is the mainstay of therapy. The role of anticoagulation is less evident in the case of bioprosthetic valves, patent foramen ovale, and dilated cardiomyopathy with low ejection fraction. Strokes due to larger artery atherosclerosis account for approximately a third of all strokes. In the case of symptomatic extracranial carotid stenosis, surgical intervention as close as possible in time to the index event seems highly beneficial. In the case of intracranial large artery atherosclerosis, the best medical therapy consists of antiplatelets, high-dose statins, aggressive controls of vascular risk factors, and lifestyle modifications, with no role for intracranial arterial stenting or angioplasty. For patients with small artery occlusion (ie, lacunar stroke), the therapy is similar to that used in patients with intracranial large artery atherosclerosis. Despite the constant new evidence on how to best treat patients who have suffered a stroke, the risk of stroke recurrence remains unacceptably high, thus evidencing the need for novel therapies. |
format | Online Article Text |
id | pubmed-4536764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-45367642015-08-21 Secondary stroke prevention: challenges and solutions Esenwa, Charles Gutierrez, Jose Vasc Health Risk Manag Review Stroke is the leading cause of disability in the USA and a major cause of mortality worldwide. One out of four strokes is recurrent. Secondary stroke prevention starts with deciphering the most likely stroke mechanism. In general, one of the main goals in stroke reduction is to control vascular risk factors such as hypertension, diabetes, dyslipidemia, and smoking cessation. Changes in lifestyle like a healthy diet and aerobic exercise are also recommended strategies. In the case of cardioembolism due to atrial fibrillation, mechanical valves, or cardiac thrombus, anticoagulation is the mainstay of therapy. The role of anticoagulation is less evident in the case of bioprosthetic valves, patent foramen ovale, and dilated cardiomyopathy with low ejection fraction. Strokes due to larger artery atherosclerosis account for approximately a third of all strokes. In the case of symptomatic extracranial carotid stenosis, surgical intervention as close as possible in time to the index event seems highly beneficial. In the case of intracranial large artery atherosclerosis, the best medical therapy consists of antiplatelets, high-dose statins, aggressive controls of vascular risk factors, and lifestyle modifications, with no role for intracranial arterial stenting or angioplasty. For patients with small artery occlusion (ie, lacunar stroke), the therapy is similar to that used in patients with intracranial large artery atherosclerosis. Despite the constant new evidence on how to best treat patients who have suffered a stroke, the risk of stroke recurrence remains unacceptably high, thus evidencing the need for novel therapies. Dove Medical Press 2015-08-07 /pmc/articles/PMC4536764/ /pubmed/26300647 http://dx.doi.org/10.2147/VHRM.S63791 Text en © 2015 Esenwa and Gutierrez. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Esenwa, Charles Gutierrez, Jose Secondary stroke prevention: challenges and solutions |
title | Secondary stroke prevention: challenges and solutions |
title_full | Secondary stroke prevention: challenges and solutions |
title_fullStr | Secondary stroke prevention: challenges and solutions |
title_full_unstemmed | Secondary stroke prevention: challenges and solutions |
title_short | Secondary stroke prevention: challenges and solutions |
title_sort | secondary stroke prevention: challenges and solutions |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536764/ https://www.ncbi.nlm.nih.gov/pubmed/26300647 http://dx.doi.org/10.2147/VHRM.S63791 |
work_keys_str_mv | AT esenwacharles secondarystrokepreventionchallengesandsolutions AT gutierrezjose secondarystrokepreventionchallengesandsolutions |